Search

Search bills, members, committees and pages...

RARE DISEASE COMPANY COALITION

23 federal lobbying filings, 2023 to 2026.

RARE DISEASE COMPANY COALITION is a client on 23 federal lobbying filings, 2023 to 2026, reporting $1.1M across them. The Rare Disease Company Coalition Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

4 it has hired, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20264$100K$180K
202511$190K$290K
20244$560K
20234$240K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
PHAPharmacy16
HCRHealth Issues9
TRDTrade (domestic/foreign)8
TAXTaxation/Internal Revenue Code7
SCIScience/Technology4
BUDBudget/Appropriations2
MMMMedicare/Medicaid1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act5
H.R. 1414Cameron’s Law4
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.3
H.R. 946ORPHAN Cures Act3
H.R. 1532Scientific EXPERT Act of 20251
H.R. 1762Forest Service Accountability Act1
H.R. 4758Homeowner Energy Freedom Act1
H.R. 7148Consolidated Appropriations Act, 20261
H.R. 7384Preventing Mass Casualties from Release of Hydrofluoric Acid at Refineries Act of 20261

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2026 second_quarter$70KJul 16, 2026
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2026 first_quarter$110KApr 20, 2026
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2026 first_quarter$50KApr 18, 2026
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2025 fourth_quarter$50KJan 20, 2026
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 fourth_quarter$70KJan 20, 2026
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2025 third_quarter$50KOct 20, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 third_quarter$90KOct 16, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 second_quarter$70KJul 18, 2025
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2025 second_quarter$50KJul 18, 2025
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2025 second_quarterMay 23, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 first_quarter$60KApr 21, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 first_quarterApr 18, 2025
RARE DISEASE COMPANY COALITIONLMH STRATEGIC SOLUTIONS2025 first_quarter$40KApr 18, 2025
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 fourth_quarter$160KJan 21, 2025
RARE DISEASE COMPANY COALITIONLMH STRATEGIC SOLUTIONS2025 first_quarterJan 10, 2025
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 third_quarter$140KOct 21, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 second_quarter$130KJul 19, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 first_quarter$130KApr 19, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 fourth_quarter$60KJan 22, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 third_quarter$60KOct 20, 2023
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 second_quarter$60KJul 19, 2023
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 first_quarter$60KApr 21, 2023